FDA Approves a New Generic Diovan (valsartan)
March 12, 2019 -- Today, the U.S. Food and Drug Administration approved a new generic of Diovan (valsartan). Valsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart failure. The FDA prioritized the review of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Diovan | Food and Drug Administration (FDA) | Heart | Heart Failure | Hypertension | Pharmaceuticals